Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (AVHHL) Gross Profit (2018 - 2025)

Historic Gross Profit for AVITA Medical (AVHHL) over the last 8 years, with Q4 2025 value amounting to $14.3 million.

  • AVITA Medical's Gross Profit fell 1125.51% to $14.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $58.8 million, marking a year-over-year increase of 663.38%. This contributed to the annual value of $58.8 million for FY2025, which is 663.38% up from last year.
  • As of Q4 2025, AVITA Medical's Gross Profit stood at $14.3 million, which was down 1125.51% from $13.9 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Gross Profit registered a high of $16.4 million during Q3 2024, and its lowest value of $5.8 million during Q1 2022.
  • Moreover, its 5-year median value for Gross Profit was $9.6 million (2024), whereas its average is $10.8 million.
  • In the last 5 years, AVITA Medical's Gross Profit surged by 17475.86% in 2021 and then plummeted by 1577.99% in 2022.
  • Over the past 5 years, AVITA Medical's Gross Profit (Quarter) stood at $5.9 million in 2021, then soared by 36.68% to $8.1 million in 2022, then soared by 52.92% to $12.4 million in 2023, then soared by 30.06% to $16.1 million in 2024, then dropped by 11.26% to $14.3 million in 2025.
  • Its last three reported values are $14.3 million in Q4 2025, $13.9 million for Q3 2025, and $14.9 million during Q2 2025.